Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Biden’s diagnosis is unfortunate but—statistically—not surprising
Trials & Tribulations

Biden’s diagnosis is unfortunate but—statistically—not surprising
Of the 384 men serving in Congress, 48 are likely to be diagnosed with prostate cancer in their lifetime

May 23, 2025
Vol.51 No.20
By Peter Nelson
Funding Opportunities

DOD prostate cancer research program FY25 funding opportunities

May 23, 2025
Vol.51 No.20
Clinical Roundup

Genetic mutation in some Ashkenazi Jewish men may be linked to higher prostate cancer risk, study shows

May 23, 2025
Vol.51 No.20
Clinical Roundup

Shorter radiation therapy after prostate surgery safe, UCLA study finds

May 16, 2025
Vol.51 No.19
Clinical Roundup

AI mapping technology outperforms MRI in predicting prostate cancer spread, study shows

May 02, 2025
Vol.51 No.17
Clinical Roundup

Cleveland Clinic Abu Dhabi performs first-ever transcontinental robotic assisted focal therapy procedure for prostate cancer

April 25, 2025
Vol.51 No.16
Clinical Roundup

UCLA test predicts which prostate cancer patients are most likely to develop long-term side effects from radiation therapy

April 11, 2025
Vol.51 No.14
Drugs & Targets

FDA approves prostate cancer imaging agent Gozellix

March 28, 2025
Vol.51 No.12
Clinical Roundup

AI tool helps predict who will benefit from focal therapy for prostate cancer, study shows

March 21, 2025
Vol.51 No.11
Clinical Roundup

Shorter radiation treatment approach shows safety and efficacy for early-stage prostate cancer

March 21, 2025
Vol.51 No.11

Posts navigation

Previous1…345…16Next

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • NCI slated to get a $9 million raise as Trump’s budget proposes about 10% cut for NIH
  • Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
  • FDA’s guidance on MRD in MM goes beyond the ODAC vote—and that’s where it matters most
    Draft guidance consolidates trial design updates for developers
  • Trump imposes up to 100% tariff on some brand name pharmaceutical companies
  • “This is not about protecting life”: Supreme Court overturn of Roe v. Wade threatens lives of cancer patients, doctors

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account